WEDNESDAY, Jan. 23, 2019 (HealthDay News) — The percentage of U.S. liver transplant recipients with alcohol-associated liver disease (ALD) doubled over 15 years, but significant regional variations remain, a new study finds. ALD has replaced hepatitis C as the most common reason for U.S. liver transplants. One reason is thatContinue Reading

(HealthDay News) — Before a new cancer treatment is available to the public, it must undergo vigorous evaluation, the American Cancer Society says. Typically, a new treatment is tested on cancer cells in a laboratory. If testing is deemed successful, there may be testing on animals, followed by testing onContinue Reading